Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
Nuwayo Ishimwe Sincere, Krishnan Anand, Sumel Ashique, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4014-4014
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Journey of PROTAC: From Bench to Clinical Trial and Beyond
Kyli Berkley, Julian Zalejski, Nidhi Sharma, et al.
Biochemistry (2025)
Closed Access | Times Cited: 3
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma-an updated review
Sumel Ashique, Md. Faiyazuddin, Obaid Afzal, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104753-104753
Closed Access | Times Cited: 13
Late-Stage Functionalization of Living Organisms: Rethinking Selectivity in Biology
Andrew M. Giltrap, Yizhi Yuan, Benjamin G. Davis
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 889-928
Open Access | Times Cited: 5
PROTAC-Based Therapeutics for Targeting HPV Oncoproteins in Head and Neck Cancers
Nobendu Mukerjee, Dibyendu Mukherjee
Nano TransMed (2025), pp. 100071-100071
Open Access
Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
Serena Rosignoli, Silvia Giordani, M Pacelli, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 206-206
Open Access
Insights From Protein Frustration Analysis of BRD4-Cereblon Degrader Ternary Complexes Show Separation of Strong from Weak Degraders
Tianyi Yang, Elizaveta Mukhaleva, Wenyuan Wei, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer’s Disease
Qiuzhi Zhou, Weixia Wang, Chunchu Deng
Molecular Neurobiology (2025)
Open Access
TACkling Cancer by Targeting Selective Protein Degradation
María del Mar Noblejas‐López, David Tébar-García, Raquel López-Rosa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2442-2442
Open Access | Times Cited: 11
BacPROTACs targeting Clp protease: a promising strategy for anti-mycobacterial drug discovery
Andressa Francielli Bonjorno, Aline Renata Pavan, Guilherme Fernandes, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 4
Potential acridinedione derivatives for the development of a heterobifunctional PROTAC for targeted degradation of PCSK9 protein
Vijay Kumar Bhardwaj, Rituraj Purohit
Applied Materials Today (2024) Vol. 38, pp. 102186-102186
Closed Access | Times Cited: 4
Novel gene therapy for drug-resistant melanoma: Synergistic combination of PTEN plasmid and BRD4 PROTAC-loaded lipid nanocarriers
Aishwarya Saraswat, Hari Priya Vemana, Vikas V. Dukhande, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102292-102292
Open Access | Times Cited: 4
Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia
Jingyu Zhang, Haiting Duan, Renzhao Gui, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115872-115872
Closed Access | Times Cited: 10
Self-Assembled Matrine-PROTAC Encapsulating Zinc(II) Phthalocyanine with GSH-Depletion-Enhanced ROS Generation for Cancer Therapy
Sitong Lai, Bing Wang, Kunhui Sun, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1845-1845
Open Access | Times Cited: 3
Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple Negative Breast Cancer Treatment
Hongye He, Feng Li, Rui Tang, et al.
Biomaterials Research (2024) Vol. 2024
Open Access | Times Cited: 3
Identification of a Sonically Activated Degrader of Methionine Adenosyltransferase 2A by an in Silico Approach Assisted with the Hole–Electron Analysis
Huan He, Ziwei Wang, Xueke Peng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 1, pp. 543-554
Closed Access | Times Cited: 2
Synergizing Proteolysis-Targeting Chimeras and Nanoscale Exosome-Based Delivery Mechanisms for HIV and Antiviral Therapeutics
Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 4, pp. 3499-3514
Closed Access | Times Cited: 2
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 2
Ubiquitin‐Independent Degradation: An Emerging PROTAC Approach?
Tiantian Li, Saskia A. Hogenhout, Weijie Huang
BioEssays (2024)
Open Access | Times Cited: 1
Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 1
Beyond Cytotoxic Potency: Disposition Features Required to Design ADC Payload
Hao Sun, Larry C. Wienkers, Anthony Lee
Xenobiotica (2024) Vol. 54, Iss. 8, pp. 442-457
Closed Access | Times Cited: 1
FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives
Heba M. Hesham, Eman M.E. Dokla, Eman Z. Elrazaz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116717-116717
Closed Access | Times Cited: 1
Stability Evaluation and Pharmacokinetic Profiling of Vepdegestrant in Rodents Using Liquid Chromatography–Tandem Mass Spectrometry
Hae-In Choi, Jin‐Young Choi, Jin Woo Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4048-4048
Open Access | Times Cited: 1
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 1
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 17, pp. 3477-3489
Open Access
Page 1 - Next Page

Scroll to top